D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $100B
1-Year Return 23.04%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Quarter Return
+4.33%
1 Year Return
+23.04%
3 Year Return
+72.12%
5 Year Return
+130.88%
10 Year Return
+299.18%
AUM
$82B
AUM Growth
+$3.66B
Cap. Flow
-$9B
Cap. Flow %
-10.97%
Top 10 Hldgs %
11.9%
Holding
4,466
New
785
Increased
1,428
Reduced
1,270
Closed
449

Sector Composition

1 Technology 19.98%
2 Consumer Discretionary 13.5%
3 Financials 10.53%
4 Healthcare 10.18%
5 Communication Services 8.22%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GOGL
3201
DELISTED
Golden Ocean Group
GOGL
$275K ﹤0.01%
+29,574
New +$275K
FNCH
3202
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$274K ﹤0.01%
+915
New +$274K
ELTX icon
3203
Elicio Therapeutics
ELTX
$188M
$270K ﹤0.01%
+9,314
New +$270K
PRQR icon
3204
ProQR Therapeutics
PRQR
$231M
$270K ﹤0.01%
+33,682
New +$270K
CYT
3205
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$270K ﹤0.01%
+23,713
New +$270K
KOD icon
3206
Kodiak Sciences
KOD
$489M
$269K ﹤0.01%
3,177
-7,314
-70% -$619K
CPT icon
3207
Camden Property Trust
CPT
$11.7B
$268K ﹤0.01%
+1,498
New +$268K
KRO icon
3208
KRONOS Worldwide
KRO
$694M
$268K ﹤0.01%
17,857
-13,008
-42% -$195K
EBET
3209
DELISTED
EBET, INC. Common Stock
EBET
$268K ﹤0.01%
+435
New +$268K
DISAW
3210
DELISTED
Disruptive Acquisition Corporation I Warrant
DISAW
$267K ﹤0.01%
333,333
SRCL
3211
DELISTED
Stericycle Inc
SRCL
$266K ﹤0.01%
4,464
-5,139
-54% -$306K
UHS icon
3212
Universal Health Services
UHS
$12.2B
$265K ﹤0.01%
2,044
-1,883
-48% -$244K
CSSE
3213
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$265K ﹤0.01%
+19,127
New +$265K
SIGI icon
3214
Selective Insurance
SIGI
$4.81B
$264K ﹤0.01%
3,219
-1,652
-34% -$135K
JHX icon
3215
James Hardie Industries plc
JHX
$11.6B
$263K ﹤0.01%
6,544
-2,735
-29% -$110K
JACK icon
3216
Jack in the Box
JACK
$350M
$263K ﹤0.01%
3,009
-12,600
-81% -$1.1M
AVDX icon
3217
AvidXchange
AVDX
$2.06B
$262K ﹤0.01%
+17,378
New +$262K
EQIX icon
3218
Equinix
EQIX
$77.2B
$261K ﹤0.01%
308
-8
-3% -$6.78K
CCVI.WS
3219
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$261K ﹤0.01%
254,981
CARG icon
3220
CarGurus
CARG
$3.58B
$260K ﹤0.01%
7,742
+1,042
+16% +$35K
BMTX
3221
DELISTED
BM Technologies, Inc.
BMTX
$260K ﹤0.01%
+28,200
New +$260K
EQRXW
3222
DELISTED
EQRx, Inc. Warrant
EQRXW
$260K ﹤0.01%
250,000
CTKB icon
3223
Cytek Biosciences
CTKB
$501M
$258K ﹤0.01%
+15,839
New +$258K
INFY icon
3224
Infosys
INFY
$70.3B
$258K ﹤0.01%
10,210
-108,398
-91% -$2.74M
ZEN
3225
DELISTED
ZENDESK INC
ZEN
$258K ﹤0.01%
2,475
-43,164
-95% -$4.5M